Margolin K.A., Wright C., Fung H.C., Kashyap A., Molina A., Nademanee A., O’Donnell M.R., Parker P., Speilberger R., Somlo G., Snyder D., Stein A., Planas I., Smith E.P., Woo D., Forman S. Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma. Biology of Blood and Marrow Transplantation 5(1):36-45, 1999.
Morgan, R.J., Braly, P., Cecchi, G, Leong, L., Shibata, S., Margolin, K., Somlo, G., McNamara, M., Longmate, J., Schinke, S., Raschko, J., Nagasawa, S., Kogut, N., Parker, P., Stein, A., Cho, J., Smith, E.P., Coluzzi, P., Nejera, L., Johnson, D., Womack, E., Doroshow, J.H. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer: Long-term follow-up. Gynecologic Oncology, 75(3):419-26, 1999.
Strobl, F. J., Voelkerding, K.V., Smith, E.P. Case Report: Management of chronic myeloid leukemia during pregnancy with leukapheresis. Journal of Clinical Apheresis 14(1):42-4, 1999.
Mineishi, S., Longo, W.L., Atkinson, M.E., Smith, E.P., Hamielec, M., Wiersma, S.R., Kinsella, T.J., Schuening, F.G. Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Bone Marrow Transplantation 23:1217-1222, 1999.
Ross M, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O’Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong, RM, Forman SJ, Blume KG, Chao NJ. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft vs. host disease: Effect on chronic graft vs. host disease and long-term survival. Biology Blood Marrow Transplant 5:285-291, 1999.
Stein AS, O’Donnell MR, Slovak ML, Nademanee A, Dagis A, Schmidt GM, Parker PM, Snyder DS, Smith EP, Somlo G, Margolin KA, Arber D, Niland J, Forman SJ. High dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non-M3 acute myelogenous leukemia: Impact of cytogenetics on achieving a complete remission. Leukemia 14:1191-1196, 2000.
Nademanee A, Molina A, Dagis A, Snyder DS, O’Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Slovak M, Noland JC, Forman SJ. Autologous Stem-Cell Transplantation for Poor-Risk and Relapsed Intermediate- and High-Grade Non-Hodgkin’s Lymphoma. Clinical Lymphoma, 1(1):46-54, 2000.
Somlo, G., Doroshow, J.H., Ahn, C., Chow, W., Hamasaki, V., Leong, L., Margolin, K., Morgan, R., Raschko, J., Shibata, S., O'Donnell, M., Smith E.P., Tetef, M., and Forman, S.J. Tandem cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies. Biology of Blood and Marrow Transplantation 7:284-293, 2001.
McCoy AG , Smith E, Atkinson ME, Baranski B, Kahl BS, Juckett J, Mitchell T, Gagnon R, Longo WL. A novel preparative regimen for autologous transplant in non-Hodgkin’s lymphoma: a long-term experience with etoposide and thiotepa. Bone Marrow Transplant 33(1): 19-24, 2004
Fung HC, Stein A, Slovak M, O’Donnell MR, Snyder DS, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R. Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somolo G, Margolin K, Chow W, Smith EP, Forman SJ. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biology of Blood and Marrow Transplant 9:766-771, 2003.
Kahl BS, Bailey HH, Smith EP, Turman N, Smith J, Werndli J, Williams EC, Longo WL, Kim KM, McGovern J, Jumonville A. Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-hodgkin’s lymphoma: a Wisconsin oncology network study. Cancer Investigation 1:13-18, 2005.
Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadimi Z, Bhatia R, Cohen S, Falk P, Fung H, Kirschbaum M, Krishnan A, Kogut N, Molina R, Nakamura R, O’Donnell M, Popplewell L, Pullarkat V, Rosenthal J, Sahebi F, Smith E, Snyder D, Somlo G, Spielberger R, Stein A, Sweetman R, Zain J, Forman S. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 11:307-313, 2005.
Fenske TS, Kahl BS, Eickhoff J, Mitchell TL, Smith EP, Atkinson E, McCoy AG, Eckstein L, Flynn B, McMannes J, Howard S, Longo WL. Excessive Toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma. Leukemia and Lymphoma 46(10): 1441-1448, 2005.
Nademanee A. Forman S. Molina A. Fung H. Smith D. Dagis A. Kwok C. Yamauchi D. Anderson AL. Falk P. Krishnan A. Kirschbaum M. Kogut N. Nakamura R. O’Donnell M. Parker P. Popplewell L. Pullarkat V. Rodriguez R. Sahebi F. Smith E. Snyder D. Stein A. Spielberger R. Zain J. White C. Raubitschek A. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. Blood 106(8):2896-902, 2005.
Rodriguez R, Nademanee A, Ruel N, Smith E, Krishnan A, Popplewell L, Zain J, Patane K, Kogut N, Nakamura R, Sarkodee-Adoo C, Forman SJ. Comparision of Reduced-Intensity and Conventional Myeloablative Regimens for Allogeneic Transplantation in Non-Hodkgin’s Lymphoma. Biology of Blood and Marrow Transplantation 12: 1326-1334, 2006.
Fung HC, Stiff P, Schriber J, Smith D, Toor A, Smith E, Rodriguez T, Krishnan A, Molina A, Ivers B, Kogut N, Popplewell L, Rodriguez R, Somlo G, Forman SJ, Nadmanee A. Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation (Accepted).
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and subject to change at any time. Last updated: 06/08.
